Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution

被引:30
|
作者
Komenaka I.K. [1 ,2 ]
Nodora J.N. [3 ]
Madlensky L. [3 ]
Winton L.M. [1 ]
Heberer M.A. [1 ]
Schwab R.B. [3 ]
Weitzel J.N. [4 ]
Martinez M.E. [3 ]
机构
[1] Maricopa Medical Center, Hogan Building, 2nd Floor, 2601 E Roosevelt Street, Phoenix, 85008, AZ
[2] Arizona Cancer Center, University of Arizona, Tucson, AZ
[3] University of California, San Diego, Moores Cancer Center, La Jolla, CA
[4] Division of Clinical Cancer Genetics, City of Hope, Duarte, CA
基金
美国国家卫生研究院;
关键词
Disparity; Genetic cancer risk assessment; Hispanic; Latina; Minority; Underinsured;
D O I
10.1007/s12687-015-0257-x
中图分类号
学科分类号
摘要
Some communities and populations lack access to genetic cancer risk assessment (GCRA) and testing. This is particularly evident in safety-net institutions, which serve a large segment of low-income, uninsured individuals. We describe the experience of a safety-net clinic with limited resources in providing GCRA and BRCA1/2 testing. We compared the proportion and characteristics of high-risk women who were offered and underwent GCRA and genetic testing. We also provide a description of the mutation profile for affected women. All 125 patients who were offered GCRA accepted to undergo GCRA. Of these, 72 % had a breast cancer diagnosis, 70 % were Hispanic, 52.8 % were non-English speakers, and 66 % did not have health insurance. Eighty four (67 %) were offered genetic testing and 81 (96 %) agreed. Hispanic women, those with no medical insurance, and those with a family history of breast cancer were significantly more likely to undergo testing (p > 0.01). Twelve of 81 (15 %) patients were found to have deleterious mutations, seven BRCA1, and five BRCA2. Our experience shows that it is possible to offer GCRA and genetic testing even in the setting of limited resources for these services. This is important given that a large majority of the low-income women in our study agreed to undergo counseling and testing. Our experience could serve as a model for similar low-resource safety-net health settings. © 2015, Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:177 / 183
页数:6
相关论文
共 50 条
  • [41] Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations
    Chopra, Ishveen
    Kelly, Kimberly M.
    JOURNAL OF HEALTH COMMUNICATION, 2017, 22 (02) : 143 - 152
  • [42] Genetic testing for women previously diagnosed with breast/ovarian cancer:: Examining the impact of BRCA1 and BRCA2 mutation searching
    Hallowell, N
    Foster, C
    Ardern-Jones, A
    Eeles, R
    Murday, V
    Watson, M
    GENETIC TESTING, 2002, 6 (02): : 79 - 87
  • [43] BRCA1/2 in high-risk African American women with breast cancer:: Providing genetic testing through various recruitment strategies
    Pal, Tuya
    Vadaparampil, Susan
    Betts, Judy
    Miree, Cheryl
    Li, Song
    Narod, Steven A.
    GENETIC TESTING, 2008, 12 (03): : 401 - 407
  • [44] The prospective risk of ovarian cancer in 1433 women in a breast cancer family history clinic: no increased risk in families testing negative for BRCA1 and BRCA2
    Evans, D. G. R.
    Ingham, S. L.
    Sahin, S.
    Buchan, I.
    Warwick, J.
    O'Hara, C.
    Moran, A.
    Howell, A.
    CANCER RESEARCH, 2012, 72
  • [45] Low Rates of African American Participation in Genetic Counseling and Testing for BRCA1/2 Mutations: Racial Disparities or Just a Difference?
    Halbert, Chanita Hughes
    Kessler, Lisa
    Collier, Aliya
    Weathers, Benita
    Stopfer, Jill
    Domchek, Susan
    McDonald, Jasmine A.
    JOURNAL OF GENETIC COUNSELING, 2012, 21 (05) : 676 - 683
  • [46] Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the US Preventive Services Task Force Recommendation
    Nelson, Heidi D.
    Pappas, Miranda
    Zakher, Bernadette
    Mitchell, Jennifer Priest
    Okinaka-Hu, Leila
    Fu, Rongwei
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (04) : 255 - 266
  • [47] BRCA1 and BRCA2 Molecular Testing in Women with Different Risk of Hereditary Breast Cancer: Cost/Effectiveness and Psychological Implications
    Stuppia, Liborio
    CURRENT WOMENS HEALTH REVIEWS, 2012, 8 (01) : 12 - 16
  • [48] Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2
    Metcalfe, K. A.
    Poll, A.
    Llacuachaqui, M.
    Nanda, S.
    Tulman, A.
    Mian, N.
    Sun, P.
    Narod, S. A.
    CLINICAL GENETICS, 2010, 78 (05) : 411 - 417
  • [49] Breast and ovarian cancer screening in women undergoing genetic counseling and genetics testing for BRCA1 and BRCA2 gene mutations.
    Kelly, KM
    Ellington, LA
    Leventhal, H
    Porter, K
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2762S - 2762S
  • [50] Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation
    Meijers-Heijboer, H
    Brekelmans, CTM
    Menke-Pluymers, M
    Seynaeve, C
    Baalbergen, A
    Burger, C
    Crepin, E
    van den Ouweland, AWM
    van Geel, B
    Klijn, JGM
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) : 1675 - 1681